Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the impact of 12 weeks of exercise on cognition in patients with end stage renal disease.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Kansas Medical Center
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT06223672 · Cognitive Decline, Cognitive Impairment
NCT07101380 · Mild Cognitive Impairment (MCI)
NCT06095297 · Long COVID, Brain Fog, and more
NCT06121544 · Alzheimer Disease, Mild Cognitive Impairment, and more
University of Kansas Medical Center
Kansas City, Kansas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions